Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

AZ, Daiichi Sankyo’s Enhertu set fair for filing in gastric cancer

AZ, Daiichi Sankyo’s Enhertu set fair for filing in gastric cancer The two companies are splitting development and marketing costs for Enhertu as well as global profits, except in Japan where Daiichi Sankyo is keeping exclusive rights.

The changing nature of approvals – what does the future hold?

The changing nature of approvals – what does the future hold? In contrast, less than 20% of new drugs were filed first in each of the other regions (Europe, Japan, RoW).

BMS expands collaboration with Nektar, sending shares soaring

BMS expands collaboration with Nektar, sending shares soaring While Opdivo was the first PD-1 inhibitor to reach the market in Europe and Japan, Merck &Co’s Keytruda’s earlier entry in the US allowed it to top Opdivo

Merck strengthens KRAS stake with Taiho and Astex partnership

Merck strengthens KRAS stake with Taiho and Astex partnership Otsuka’s Taiho has retained co-commercialisation rights in Japan, with the option to promote in certain areas of South East Asia.

Wave’s challenge to Sarepta in Duchenne falls flat

Wave’s challenge to Sarepta in Duchenne falls flat The demise of Wave’s programmes leaves Japan’s Nippon Shinyaku Pharma as the main rival to Sarepta in DMD.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
The art of delivering valuable customer journeys aligned to your key messages in 2020...
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...

Infographics